NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 148 filers reported holding NOVAVAX INC in Q4 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $217,000 | -35.2% | 172,327 | +6.8% | 0.00% | – |
| Q3 2016 | $335,000 | -71.2% | 161,349 | +0.7% | 0.00% | -100.0% |
| Q2 2016 | $1,165,000 | +39.4% | 160,306 | -1.0% | 0.00% | – |
| Q1 2016 | $836,000 | -39.1% | 161,878 | -1.0% | 0.00% | -100.0% |
| Q4 2015 | $1,373,000 | +17.3% | 163,573 | -1.3% | 0.00% | 0.0% |
| Q3 2015 | $1,171,000 | +7.2% | 165,673 | +69.0% | 0.00% | 0.0% |
| Q2 2015 | $1,092,000 | +135.3% | 98,027 | +74.4% | 0.00% | – |
| Q1 2015 | $464,000 | +34.5% | 56,195 | -3.3% | 0.00% | – |
| Q4 2014 | $345,000 | +49.4% | 58,128 | +4.7% | 0.00% | – |
| Q3 2014 | $231,000 | -11.2% | 55,527 | -1.3% | 0.00% | – |
| Q2 2014 | $260,000 | -44.3% | 56,271 | -45.4% | 0.00% | – |
| Q1 2014 | $467,000 | +4.5% | 103,096 | +18.2% | 0.00% | – |
| Q4 2013 | $447,000 | +96.9% | 87,192 | +21.0% | 0.00% | – |
| Q3 2013 | $227,000 | +233.8% | 72,058 | +116.0% | 0.00% | – |
| Q2 2013 | $68,000 | – | 33,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |